2022
DOI: 10.1016/j.neo.2022.01.001
|View full text |Cite
|
Sign up to set email alerts
|

UALCAN: An update to the integrated cancer data analysis platform

Abstract: Cancer genomic, transcriptomic, and proteomic profiling has generated extensive data that necessitate the development of tools for its analysis and dissemination. We developed UALCAN to provide a portal for easy exploring, analyzing, and visualizing these data, allowing users to integrate the data to better understand the gene, proteins, and pathways perturbed in cancer and make discoveries. UALCAN web portal enables analyzing and delivering cancer transcriptome, proteomics, and patient survival data to the ca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
659
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 845 publications
(667 citation statements)
references
References 24 publications
7
659
0
1
Order By: Relevance
“…RPPA profiling data can classify tumors according to subtype, where RPPA antibody-based features may also lend themselves to relevant immunohistochemistry studies. For all cancer types studied, we have added the proteomic datasets to the user-friendly UALCAN data portal 26 , 48 , facilitating differential analyses by protein, giving the research community ready access to our results.…”
Section: Discussionmentioning
confidence: 99%
“…RPPA profiling data can classify tumors according to subtype, where RPPA antibody-based features may also lend themselves to relevant immunohistochemistry studies. For all cancer types studied, we have added the proteomic datasets to the user-friendly UALCAN data portal 26 , 48 , facilitating differential analyses by protein, giving the research community ready access to our results.…”
Section: Discussionmentioning
confidence: 99%
“…Transcriptome data of 647 CRC cases and 51 adjacent tumor samples were collected and analyzed from TCGA database ( McCain, 2006 ). Furthermore, multiple databases are used together to validate the MT1G expression, such as GEPIA2 ( Tang et al, 2019 ), UALCAN ( Chandrashekar et al, 2022 ), and TNMplot ( Bartha and Győrffy, 2021 ).…”
Section: Methodsmentioning
confidence: 99%
“… 30 Kaplan–Meier analysis for UCEC was derived from the TCGA database and generated by the UALCAN web platform. 31 Alterations of Cyclin D3 in UCEC data were derived from TCGA database and generated by the cBio Cancer Genomics Portal platform. 32 …”
Section: Methodsmentioning
confidence: 99%